Eye on FDA
A series focused on important FDA and related regulatory developments critical to the life sciences industry.
Filter by Category
Search Results
Eye on FDA
In the last two weeks, the Department of Health and Human Services (HHS) has filled key artificial intelligence (AI) positions at HHS and the U.S. Food and Drug Administration (FDA). These appointments, as well as recent statements from HHS and FDA leadership, align with the Trump administration’s intention to use AI to improve regulatory efficiency at HHS and beyond.